Clinical presentation and outcome of colorectal cancer in HIV-positive patients: A clinical case-control study

Onkologie

Volumn 32, Issue 6, 2009, Pages 319-324

  Berretta, Massimiliano ^a   Cappellani, Alessandro ^b   Di Benedetto, Fabrizio ^c   Lleshi, Arben ^a   Talamini, Renato ^a   Canzonieri, Vincenzo ^a   Zanet, Ernesto ^a   Bearz, Alessandra ^a   Nasti, Guglielmo ^d   Lacchin, Teresa ^a   Berretta, Salvatore ^b   Fisichella, Rossella ^b   Balestreri, Luca ^a   Torresin, Augusta ^e   Izzi, Immacolata ^f   Ortolanik, Patrizia ^g   Tirellia, Umberto ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e GALLIERA HOSPITAL   (Italy)

^f CATHOLIC UNIVERSITY   (Italy)

^g 'Infermi' Hospital   (Italy)

Author keywords

Colorectal cancer; HIV

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER REGISTRY; CANCER SURVIVAL; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; DIARRHEA; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MALE; MEDICAL INFORMATION; MULTIMODALITY CANCER THERAPY; NAUSEA; NEUTROPENIA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIPHERAL NEUROPATHY; THROMBOCYTOPENIA;

ADULT; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; COMORBIDITY; FEMALE; HIV INFECTIONS; HUMANS; ITALY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 67650260796     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000215719     Document Type: Article

References (27)

1. Cooley TP: Non-AIDS-defining cancer in HIV-infected people. Hematol Oncol Clin North Am 2003;17:889-899.
2. Levine AM: AIDS-related malignancies: The emerging epidemic. J Natl Cancer Inst 1993;85:1382-1397.
3. Wang CY, Snow JL, Su WP: Lymphoma associated with human immunodeficiency virus infection. Mayo Clin Proc 1995;70:665-672.
4. Berretta M, Cinelli R, Martellotta F, Spina M, Vac-cher E, Tirelli U: Therapeutic approaches to AIDS-related malignancies. Oncogene 2003;22:6646-6659.
5. Patel P, Hanson DL, Sullivan PS, Novak RM, Moorman AC, Tong TC, Holmberg SD, Brooks JT: Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 2008;148:728-736.
6. Bedino R, Chen RY, Accort NA, Raper JL, Linn C, Allinson JJ, Raper JL, Linn C, Allison JJ, Dubay J, Saag MS, Hoesley CJ: Trends in AIDS-defin-ing and non-AIDS defining malignancies among HIV-infected patients: 1989-2002. Clin Infect Dis 2004;39:1380-1384.
7. Bonnet F, Lewden C, May T, Heripret L, Jougla E, Bevilacqua S, Costagliola D, Salmon D, Chene G, Morlat P: Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer 2004;101:317-324.
8. Stewart WB, Kleihues P: World cancer report 2003 IARC. www.iarc.fr/WCR/.
9. Berretta M, Simonelli C, Lleshi A, Lacchin T, Bearz A, di Gennaro G, Vaccher E, Tirelli U: Oxaliplatin-based chemotherapy in association with highly active antiretroviral therapy in metastatic colorectal cancer HIV-infected patients. Ann Oncol 2006;17:721-722.
10. Berretta M, Di Benedetto F, Simonelli C, Bearz A, Berretta S, Maugeri D, Tirelli U: Multidisciplinary approach in a HIV/HCV-positive patient with liver metastases by colorectal cancer in the HAART era. Ann Oncol 2006;17:1333-1334.
11. Berretta M, Martellotta F, Simonelli C, Di Benedetto F, De Ruvo N, Drigo A, Bearz A, Spina M, Zanet E, Berretta S, Tirelli U: Cetuximab targeted chemotherapy in an HIV-positive patient with metastatic colorectal cancer in the HAART era: a case report. J Chem 2007;19:343-346.
12. Berretta M, Martellotta F, Lanzafame M, Montesarchio V, Ortolani P, Cinelli R, Di Benedetto F, Spina M, Lleshi A, Bearz A, Simonelli C, Tirelli U: FOLFOX4 and concomitant highly active antiretroviral therapy (HAART) in metastatic colorectal cancer (M-CRC) HIV-positive patients (pts): A GICAT experience. ASCO 44th Annual Meeting, Chicago, IL, May 30-June 03, 2008.
13. Ancelle-Park R: Expanded European AIDS case definition (letter). Lancet 1993;341:441.
14. Breslow NE, Day NE: Statistical methods in cancer research. Vol. I: The analysis of case-control studies. IARC Sci Publ 1980;32:5-338.
15. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
16. Cox DR: Regression models and life tables. J R Stat Soc B 1997;234:187-220.
17. Dal Maso L, Serraino D, Franceschi S: Epidemiology of AIDS-related tumours in developed and developing countries. Eur J Cancer 2001;37:1188-1201.
18. Bini EJ, Park J, Francois F: Use of flexible sigmoidoscopy to screen for colorectal cancer in HIV-infected patients, 50 years of age and older. Arch Intern Med 2006;166:1626-1631.
19. Yeguez JF, Martinez S, Sands D, Sands LR, Hell-inger MD: Colorectal malignancies in HIV-positive patients. Am Surg 2003;11:981-987.
20. Wasserberg N, Nunoo-Mensah JW, Gozalez-Ruiz C, Beart RW Jr, Kaiser AM: Colorectal cancer in HIV-infected patients: a case control study. Int J Colorectal Dis 2007;22:1217-1221.
21. Frisch M, Biggar RJ, Engels EA, Goedert JJ; AIDS-Cancer Match Registry Study Group: Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001;285:1736-1745.
22. Gallagher B, Wang Z, Schymura MJ, Kahn A, Fordyce EJ: Cancer incidence in New York State acquired immunodeficiency syndrome patients. Am J Epidemiol 2001;154:544-556.
23. Reinhold JP, Moon M, Tenner CT, Poles MA, Bini EJ: Colorectal cancer screening in HIV-infected patients 50 years of age and older: missed opportunities for prevention. Am J Gastroenterol 2005;100:1805-1812.
24. Rodrigues LK, Klencke BJ, Vin-Christian K, Berger TG, Crawford RI, Miller JR 3rd, Ferreira CM, Nostrati M, Kashani-Sabet M: Altered clinical course of malignant melanoma in HIV-positive patients. Arch Dermatol 2002;138:765-770.
25. Mbulaiteye SM, Biggar RJ, Goedebert JJ, Engels EA: Immune deficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr 2003;32:527-533.
26. Pantanowitz L, Schlecht HP, Dezube BJ: The growing problem of non-AIDS-defining malignancies in HIV. Curr Opin Oncol 2006;18:469-478.
27. Biggar RJ: AIDS-related cancers in the era of highly active antiretroviral therapy. Oncology 2001; 15:439-448.